# Childhood B-acute Lymphoblastic Leukaemia and Role of CD9 Gene Regulation in Relapse

> **NCT06649253** · NA · RECRUITING · sponsor: **Rennes University Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Leukemia, Lymphoblastic, Acute, Pediatric

## Interventions

- **OTHER:** Sampling bone tissue and blood

## Key facts

- **NCT ID:** NCT06649253
- **Lead sponsor:** Rennes University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-22
- **Primary completion:** 2035-04
- **Final completion:** 2035-04
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-01-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06649253

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06649253, "Childhood B-acute Lymphoblastic Leukaemia and Role of CD9 Gene Regulation in Relapse". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06649253. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*